COVID-19 Archives - BioTuesdays

Developments

University of Cambridge begins COVID-19 trial with PharmaJet needle-free system

PharmaJet’s needle-free Injection system will be used in a clinical trial to deliver a booster vaccine against COVID-19 virus variants. The vaccine developed by DIOSynVax, a spinoff company supported by the University...

January 18, 2022

Developments

Sigyn outlines 2021 achievements; 2022 clinical, corporate outlook

In a letter to shareholders, chairman and CEO, Jim Joyce of Sigyn Therapeutics (OTC:SIGY), said that in the face of a pandemic that paused and shuttered numerous clinical research programs, “we translated our vision for...

January 4, 2022

Developments

PharmaJet partner Zydus Cadila in COVID-19 vaccine expansion with Korean firm

Needle-free injection company PharmaJet’s partner, Zydus Cadila, is partnering with Enzychem Lifesciences to manufacture their COVID-19 plasmid DNA vaccine, ZyCoV-D, in Korea. The plan is to manufacture more than 80...

January 4, 2022

Developments

Altamira updates Bentrio EU roll-out, 510(k), new Asian distribution, COVID-19, allergy testing

Altamira Therapeutics (NASDAQ:CYTO) issued a business update on Bentrio, its nasal spray for protection against airborne viruses and allergens. The company has set up contracts with wholesalers in its lead market of...

December 30, 2021

Markets

Cantor starts Cardiol at OW; PT $8

Cantor Fitzgerald launched coverage of Cardiol Therapeutics (NASDAQ:CRDL) with an “overweight” rating and price target of $8. The stock closed at $1.87 on Dec. 16. Cardiol is a clinical-stage, platform-enabled...

December 17, 2021

Executive Moves

Ondine Biomedical appoints renowned Prof Trevor Jones to lead COVID-19 advisory board

Ondine Biomedical (LSE:OBI), appointed Prof. Trevor Jones, CBE FMedSci, to lead a new advisory board on the use of its pioneering photodisinfection-based technology to prevent and treat COVID-19. Ondine’s non-antibiotic...

December 15, 2021

Developments

Omicron variant underscores need for new COVID vaccine candidates like IBIO-202

iBio (NYSE American:IBIO) provided an updated on its lead COVID-19 vaccine program, IBIO-202, in light of the emergence of the Omicron variant of SARS-CoV-2. According to the WHO, the Omicron variant has at...

November 29, 2021

Developments

Oramed, Genomma Lab in JV for oral COVID-19 vaccine in Mexico; BD in Latin America

Oravax Medical, a unit of Oramed Pharmaceuticals (NASDAQ, TASE:ORMP), and Genomma Lab Internacional (BMV:LABB) formed of a 50/50 joint venture to develop and commercialize Oravax’s oral COVID-19 vaccine candidate...

November 18, 2021

Developments

South Africa clears Phase 1 trial for Oramed oral COVID-19 vaccine

Oramed Pharmaceuticals’ (NASDAQ, TASE:ORMP) majority-owned subsidiary, Oravax Medical, received clearance from the South African Health Products Regulatory Authority to begin patient enrollment in a first-in...

October 29, 2021

Developments

PharmaJet to deliver Scancell COVID-19 DNA vaccines

Closely-held PharmaJet was selected by partner, Scancell, to administer its two SARS-CoV-2 DNA vaccine candidates, SCOV1 and SCOV2, using the PharmaJet Tropis and PharmaJet Stratis Needle-free injection...

September 14, 2021

Tag - COVID-19

University of Cambridge begins COVID-19 trial with PharmaJet needle-free system

Sigyn outlines 2021 achievements; 2022 clinical, corporate outlook

PharmaJet partner Zydus Cadila in COVID-19 vaccine expansion with Korean firm

Altamira updates Bentrio EU roll-out, 510(k), new Asian distribution, COVID-19, allergy testing

Cantor starts Cardiol at OW; PT $8

Ondine Biomedical appoints renowned Prof Trevor Jones to lead COVID-19 advisory board

Omicron variant underscores need for new COVID vaccine candidates like IBIO-202

Oramed, Genomma Lab in JV for oral COVID-19 vaccine in Mexico; BD in Latin America

South Africa clears Phase 1 trial for Oramed oral COVID-19 vaccine

PharmaJet to deliver Scancell COVID-19 DNA vaccines

General

More

Sign up for the BioTuesdays weekly newsletter